Implanon Nxt (Etonogestrel)

Etonogestrel, the active ingredient in Implanon Nxt, is a progestin presented as a 68 mg subcutaneous implant for subcutaneous use. It prevents pregnancy by providing long‑acting hormonal contraception for women of reproductive age. The implant releases a consistent dose of etonogestrel for up to three years, removing the requirement for daily pills.

GNH USA supplies Implanon Nxt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality assurance, regulatory compliance and reliable logistics for global distribution needs.

Etonogestrel is a progestin used in hormonal contraception to prevent pregnancy.

- Contraception: provides continuous birth control for up to three years without daily dosing. - Long‑acting reversible contraception: offers a reliable, implantable method that can be removed when pregnancy is desired. - Hormonal birth control: suppresses ovulation and thickens cervical mucus to prevent fertilization.

Etonogestrel implants may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Irregular bleeding or spotting - Amenorrhea (absence of periods) - Headache - Breast tenderness - Acne or oily skin - Weight gain

Serious or Rare Side Effects: - Ectopic pregnancy - Pelvic inflammatory disease - Implant site infection - Severe allergic reaction (anaphylaxis) - Thromboembolic events (deep vein thrombosis, pulmonary embolism) - Hormone‑dependent tumor progression (rare)

Before initiating Implanon Nxt, healthcare providers should evaluate patient history and follow specific safety measures.

- Medical assessment: screen for active liver disease, thromboembolic disorders, or hormone‑sensitive cancers. - Pregnancy status: confirm the patient is not pregnant prior to insertion. - Breastfeeding: discuss potential benefits and risks with lactating women. - Medication review: identify drugs that may reduce contraceptive effectiveness. - Follow‑up care: schedule visits to check implant position and manage bleeding patterns. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Etonogestrel’s contraceptive efficacy can be altered by concomitant medications that affect hormone metabolism.

Major Interactions (Avoid): - Enzyme inducers (e.g., rifampin, carbamazepine, phenytoin): may significantly lower etonogestrel levels. - Protease inhibitor antiretrovirals: can interfere with hormone metabolism.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., ketoconazole): may increase hormone concentrations. - St. John’s wort herbal supplement: may reduce contraceptive effectiveness. - Certain antibiotics (e.g., ampicillin): generally minimal effect but monitor for breakthrough bleeding.